Axinn Represents Park Place Technologies, GTCR, and Charlesbank in Park Place’s Acquisition by Service Express
January 7, 2026
Axinn is pleased to represent Park Place Technologies (“Park Place”), together with its existing sponsors GTCR and Charlesbank Capital Partners, as global coordinating antitrust counsel in Park Place’s acquisition by Service Express, a Warburg Pincus portfolio company. Park Place and Service Express have merged to create a global data center services company with more than 3,000 employees and more than 25,000 customers across North America, Europe, Asia, and South America.
The merged company is positioned to deepen support across traditional, cloud, and AI-accelerated environments, with expanded geographic coverage and a broader range of technical capabilities.
The Axinn team included partners John Harkrider, Craig Minerva, counsel Carol Xianxiao Liu, and Axinn associates.
About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth, always thinking ahead.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust